Bio Solution Co.,Ltd. (KOSDAQ:086820)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,950.00
-400.00 (-4.28%)
At close: Feb 27, 2026
Market Cap216.34B +1.7%
Revenue (ttm)8.27B -6.8%
Net Income-1.28B
EPS-53.69
Shares Out24.17M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume176,062
Average Volume239,468
Open9,270.00
Previous Close9,350.00
Day's Range8,900.00 - 9,650.00
52-Week Range7,050.00 - 13,200.00
Beta0.35
RSI57.48
Earnings DateMar 17, 2026

About Bio Solution

Bio Solution Co.,Ltd. develops, manufactures, and sells cell therapy products worldwide. The company offers CartiLife, an autologous chondrocyte cell-based therapy for the restoration of symptomatic and structural complications caused by articular cartilage defects; KeraHeal-Allo, a thermosensitive hydrogel-type allogenic keratinocyte cell-therapy product to promote re-epithelialization of deep 2nd-degree burn wounds; and KeraHeal, an autologous spray-type keratinocyte cell-based therapy for skin wounds. It also provides reconstructed human mic... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2000
Employees 71
Stock Exchange KOSDAQ
Ticker Symbol 086820
Full Company Profile

Financial Performance

Financial Statements